BRCA1 and breast cancer: Triple-negative breast cancer (TNBC), a biological and clinically heterogeneous disease, accounts for 15 to 20% of all breast cancers (BC) and is more common in premenopausal women or those with breast cancer gene 1 (BRCA1) gene mutation [1].